Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Trilaciclib

Trilaciclib is listed in the pharmaceutical impurity collection under CAS 1374743-00-6. Its represented structure has formula C24H30N8O and a calculated molecular weight of 446.56 g/mol.

2D chemical structure

N N N H N N N H N O N

Chemical identity

Catalog name
Trilaciclib
Common name
Trilaciclib
Chemical name
4-[[5-(4-methylpiperazin-1-yl)-2-pyridinyl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one
CAS
1374743-00-6
SMILES
CN1CCN(c2ccc(Nc3ncc4cc5n(c4n3)C3(CCCCC3)CNC5=O)nc2)CC1
InChI
InChI=1S/C24H30N8O/c1-30-9-11-31(12-10-30)18-5-6-20(25-15-18)28-23-26-14-17-13-19-22(33)27-16-24(7-3-2-4-8-24)32(19)21(17)29-23/h5-6,13-15H,2-4,7-12,16H2,1H3,(H,27,33)(H,25,26,28,29)
InChIKey
PDGKHKMBHVFCMG-UHFFFAOYSA-N

Record ID: Ace60e50e552e

Computed properties

C24H30N8O Molecular formula
446.559 g/molMolecular weight
446.2543 DaMonoisotopic exact mass
91.21 ŲTopological polar surface area
2.7245 Calculated LogP (Wildman–Crippen)
128.1499 cm³/molMolar refractivity (Wildman–Crippen)
7 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 8 16 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight446.55978.20
Calculated LogP (Wildman–Crippen)2.724556.42
Topological polar surface area91.2166.41
Hydrogen-bond acceptors783.12
Hydrogen-bond donors264.87
Rotatable bonds (strict)337.08

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC24H30N8Odimensionless
Molecular weight446.559g/mol
Monoisotopic exact mass446.2543Da
Topological polar surface area91.21Ų
Calculated LogP (Wildman–Crippen)2.7245dimensionless
Molar refractivity (Wildman–Crippen)128.1499cm³/mol
Hydrogen-bond acceptors7count
Hydrogen-bond donors2count
Rotatable bonds (strict)3count
Heavy atoms33count
Heteroatoms9count
Rings6count
Aromatic rings3count
Aliphatic rings3count
Saturated rings2count
Aromatic heterocycles3count
Aliphatic heterocycles2count
Saturated heterocycles1count
Aromatic carbocycles0count
Aliphatic carbocycles1count
Fraction of sp³ carbon atoms0.5fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms1count
Bridgehead atoms0count
Labute approximate surface area192.7559Ų
Valence electrons172count
Radical electrons0count
Bertz complexity1,173.1424index
Balaban J1.2859index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Trilaciclib

Qualification and safety assessment of Trilaciclib

Explore toxicological qualification of Trilaciclib and ICH M7 mutagenic impurity assessment of Trilaciclib for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Trilaciclib and acceptable intake and limit justification for Trilaciclib. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Trilaciclib

Explore Altox services and software through the Altox Pharma-Hub.